|
| |
| | EID Vol 2 No 4: |
 | | Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. | | | The reason for the vaccine's poor immunogenicity and its lack of efficacy in children is thought to be the nature of the PS antigen. | | | Safety and immunogenicity of a pentavalent pneumococcal conjugate vaccine in healthy toddlers. |
|
http://www.cdc.gov/ncidod/EID/vol2no4/kayhty.htm
|
|
| |
| | Haemophilus b Conjugate Vaccines for Prevention of Haemophilus influenzae Type b Disease Among Infants and Children Two ... |
| | Immunogenicity studies of each of the three conjugate vaccines have been performed among 2- to 6-month-old children. | | | However, situations will arise in which the vaccine provider does not know which type of Hib conjugate vaccine the child to be vaccinated had previously received. | | | Recent studies among Alaskan Native infants and infants in California, however, suggest that the three conjugate vaccines induce markedly different immunologic responses (5,6) ( Table_2). |
|
http://www.cdc.gov/mmwr/preview/mmwrhtml/00041736.htm
|
|
| |
| | IMMUNOGENICITY OF FDA DTP VERSUS WHO DTP |
| | There is a need for methods of potency assay to be re-evaluated. | | | The authors acknowledge with thanks the effort of the physicians working in the health centers included in the study, particularly Dr. H.A. Al-Sawi. | | | A study which was done in Australia showed that the increase in diphtheria or tetanus concentration was not associated with an increase in the reported systemic or local clinical signs associated with the first three doses. |
|
http://www.kfshrc.edu.sa/annals/195/98-271.html
|
|
| |
| | immunogenicity |
| | Immunogenicity of Recombinant Biological Therapeutics: A Practical Approach October 18-19, 2004 San Francisco, CA November 8-9, 2004 Boston, MA Instructors... | | | immunogenicity The ability to elicit an immune response. | | | The Phase IIb immunogenicity study will include a total of 200 patients in approximately 10 of the leading cardiothoracic centers in the United States. |
|
http://www.biometnews.com/biotechnology/immunogenicity.html
|
|
| |
| | Science's AIDScience Archive |
| | A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects | | | A Phase I Safety and Immunogenicity Study Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects | | | A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic in HIV-1 Seronegative Human Subjects |
|
http://aidscience.org/allvaccines.asp
|
|
| |
| | Antitope Ltd - Evaluating Immunity |
| | These results corresponded with the frequency of immunogenicity observed clinically with the various preparations. | | | Our primary focus is to apply and improve upon existing technologies that model human immune responses to protein antigens. | | | At Antitope, we pride ourselves on providing tailored projects to meet our clients' needs. |
|
http://www.antitope.com
|
|
| |
| | Gerd Ritter |
| | Many factors will influence the immunogenicity of a therapeutic antibody. | | | The BIACORE method used in this study fulfills these criteria and is now being utilized in all our studies with humanized antibodies. | | | To date, only limited information is available on the immunogenicity of humanized therapeutic antibodies in cancer patients. |
|
http://www.cancerresearch.org/antibodies2002/gerd_ritter.html
|
|
| |
| | Virtual Naval Hospital: Guide to Clinical Preventive Services, Second Edition |
| | A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids: outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children. | | | Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age. | | | A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. |
|
http://www.vnh.org/GCPS2/75.html
|
|
| |
| | University of Maryland School of Medicine - Center for Vaccine Development |
| | Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated guaBA Salmonella enterica serovar Typhi strain CVD 915. | | | A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. | | | Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae 01 in rabbit intestine. |
|
http://medschool.umaryland.edu/cvd/publications.asp
|
|
| |
| | Jornal de Pediatria - Immunogenicity of hepatitis B vaccination in preterm infants started soon after birth: ... |
| | While vaccination of premature babies can be delayed, it can become necessary to vaccinate as early as the first 12 hours postpartum if the child's mother is known to be positive for HBsAg or if her infectious status is unknown. | | | Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. | | | Nevertheless, research into the immunogenicity of early vaccination (begun during the first few days of life) of preterm NB has been inconclusive with disagreement between the various studies available in published literature. |
|
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572004000200003&lng=en&nrm=iso&tlng=en
|
|
| |
| | Immunology, Biology 328 |
| | However, certain conditions must be satisfied in order for a molecule to be immunogenic. | | | Immunogens For the induction of humoral immunity (antibody response), the most potent immunogens are macromolecular proteins or glycoproteins, but polysaccharides, synthetic peptides, and other synthetic polymers such as polyvinylpyrrolidone are immunogenic under appropriate conditions. | | | Too little may not stimulate a strong response, too much may stimulate tolerance. |
|
http://bioweb.wku.edu/faculty/Davis/Biol328/Lecture5.html
|
|
| |
| | Peptides, NIAID Division of AIDS, HIV Vaccine Site |
| | In no case, however, the boost effect of the peptide resulted in broadening of the neutralization response to make it effective against primary isolates. | | | Controlled-released microparticles and iscom matrix technologies have also been applied to peptide vaccines, however, no extended immunogenicity evaluations of the latter approaches have been conducted. | | | Limited studies in humans (including HIV seropositive volunteers) have confirmed such immunogenicity: antibody responses, proliferative and CTL responses were generated after 3 doses of the vaccine; adoptive transfer of cells from vaccinees have been shown to protect SCID mice from challenge with HIV-1. |
|
http://www.niaid.nih.gov/daids/vaccine/peptides.htm
|
|
| |
| | : The AMEDEO Literature Guide |
| | Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia. | | | Immunogenicity of Inactivated Hepatitis A Vaccine in Children With Chronic Liver Disease. | | | Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. |
|
http://www.amedeo.com/medicine/vac/pedinf.htm
|
|
| |
| | Prevention Guidelines |
| | Hib vaccine is immunogenic in patients with increased risk for invasive disease, such as those with sickle-cell disease (46), leukemia (47), human immunodeficiency virus (HIV) infection (48,49), and in those who have had splenectomies (50). | | | However, in persons with HIV infection, immunogenicity varies with stage of infection and degree of immunocompromise. | | | These children should be considered unimmunized, and vaccination should start as soon as possible during the convalescent phase of the illness. |
|
http://www.phppo.cdc.gov/cdcRecommends/showarticle.asp?a_artid=P0000326&TopNum=100&CallPg=Adv
|
|
| |
| | : The AMEDEO Literature Guide |
| | Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines. | | | Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial. | | | Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy. |
|
http://www.amedeo.com/medicine/vac/infimm.htm
|
|
| |
| | XOMA Licensing Opportunities - Human Engineering™ |
| | In Phase I clinical trials, XOMA demonstrated that Human Engineered™ ING-1 had no detectable immunogenicity in the vast majority of patients as detected by a sensitive assay. | | | The incidence of an immune response to ING-1 was both low and similar to that reported for other humanized antibodies. | | | The technology uses a unique algorithm developed at XOMA, based on analysis of the conserved structure-function relationships among antibodies. |
|
http://www.xoma.com/licensing_opportunities/human_engr.jsp
|
|
| |
| | [No title] |
| | Immunogenicity of expressed Hsp60 protein was evaluated with animal experiments. | | | RESULTS: DNA sequence analysis showed Hsp60 DNA was the same as GenBank¡¯s research. | | | AIM: To express Hsp60 protein of H pylori by a constructed vector and to evaluate its immunogenicity. |
|
http://www.wjgnet.com/1007-9327/9/2711.asp
|
|
| |
| | Full Text: Immunogenicity of Hylan G-F 20 in Guinea Pigs and Mice |
| | Recent reported severe acute inflammatory reactions in human patients after repeated intraarticular injections of hylan G-F 20 might involve product-specific, immune-mediated mechanisms. | | | To determine the product-specific immunogenicity of a chemically-modified sodium hyaluronate derivative, hylan G-F 20, that is used in the treatment of osteoarthritis of the knee. | | | The sera of hylan-immunized guinea pigs showed positive reaction in the homologous PCA assay and significantly high amount of anti-hylan IgG, whereas the sera did not show any cross-reactivity against sodium hyaluronate. |
|
http://www.jrheum.com/abstracts/abstracts04/943.html
|
|
| |
| | Field evaluation of the efficacy and immunogenicity of recombinant hepat |
| | sandorandfay@extra.co.nz [Medline record in process] A study involving more than 2,000 infants was conducted in Vietnam to assess the field effectiveness and immunogenicity of recombinant hepatitis B vaccine given at birth, 1 month, 2 months, without concomitant hepatitis B immune globulin (HBIG). | | | Next by Date: Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan | | | Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants |
|
http://archive.mail-list.com/hbv_research/msg03750.html
|
|
| |
| | Immunogenicity Testing |
| | We will serve you by providing assurance of the level of immunogenicity of your product.In early clinical testing we can provide a sensitive, specific assay to evaluate your trial patients independently and confidentially. | | | Knowing the importance of establishing a standardized assay during development, we have experience in developing assays and writing GMP/GLP procedures acceptable to regulatory agencies. | | | Our certification by BSI as ISO13485 compliant assures you of this level of quality. |
|
http://www.antibodiesinc.com/CatalogProducts.asp?nProductsID=166
|
|
|
